Preoperative cataract surgery use of an intravitreal dexamethasone implant (Ozurdex) in a patient with juvenile idiopathic arthritis and chronic anterior uveitis.

Abstract

We report a 6-year-old boy with anterior uveitis associated with juvenile idiopathic arthritis (JIA) who underwent cataract extraction in his right eye. One month before surgery he received an intravitreal sustained-release dexamethasone implant. During 10 months' follow-up, his uveitis remained quiet. To our knowledge this is the first report using an intravitreal sustained-release dexamethasone implant as a perioperative anti-inflammatory medication.

• Authors: Miguel Cordero-Coma, Irene Garzo, Sara Calleja, Elena Galán, Manuel Franco, José G Ruíz de Morales
• Journal: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus (J AAPOS) Vol. 17 Issue 6 Pg. 632-4 (Dec 2013) ISSN: 1528-3933 [Electronic] United States
• PMID: 24215803 (Publication Type: Case Reports, Journal Article)
• Copyright: Copyright © 2013 American Association for Pediatric Ophthalmology and Strabismus. Published by Mosby, Inc. All rights reserved.

Chemical References

• Anti-Inflammatory Agents
• Drug Implants
• Dexamethasone

Topics

• Anti-Inflammatory Agents (administration & dosage)
• Arthritis, Juvenile (complications)
• Cataract Extraction
• Child
• Chronic Disease
• Dexamethasone (administration & dosage)
• Drug Implants
• Humans
• Intravitreal Injections
• Male
• Preoperative Care (methods)
• Treatment Outcome
• Uveitis, Anterior (therapy)